Page last updated: 2024-11-02

pioglitazone and Complication, Postoperative

pioglitazone has been researched along with Complication, Postoperative in 3 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

Excerpt	Relevance	Reference
"To examine the impact of a recent surgery on development of endometriosis-related adhesions in a chimeric model and to determine the therapeutic efficacy of pioglitazone (PIO)."	3.77	Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis. ( Bruner-Tran, KL; Camargos, AF; Carvalho-Macedo, AC; Crispens, MA; Herington, JL; Lebovic, DI; Osteen, KG, 2011)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Lo, C	1
Toyama, T	1
Oshima, M	1
Jun, M	1
Chin, KL	1
Hawley, CM	1
Zoungas, S	1
Zhang, Z	1
Yuan, H	1
Zhao, H	1
Qi, B	1
Li, F	1
An, L	1
Herington, JL	1
Crispens, MA	1
Carvalho-Macedo, AC	1
Camargos, AF	1
Lebovic, DI	1
Bruner-Tran, KL	1
Osteen, KG	1

Clinical Trials (12)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Efficacy and Safety of Empagliflozin Compared With Linagliptin in New-onset Diabetes Mellitus After Kidney Transplantation[NCT03642184]	Phase 4	6 participants (Actual)	Interventional	2018-07-14	Terminated (stopped due to Difficult in enrolling suitable participants)
Influence of Pioglitazone for Renal Transplant Function in Diabetics - a Double Blind Randomised Placebo Controlled Cross Over Study[NCT00507494]	Phase 3	0 participants	Interventional	2007-07-31	Completed
Treat-To-Target Trial of Continuous Subcutaneous, Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation (SAPT-NODAT)[NCT01680185]	Phase 3	85 participants (Actual)	Interventional	2012-08-31	Completed
A Randomized Controlled Trial of Pioglitazone on Insulin Resistance, Insulin Secretion and Atherosclerosis in Renal Allograft Recipients Without History of Diabetes[NCT00598013]		83 participants (Actual)	Interventional	2004-11-30	Completed
Vildagliptin in New Onset Diabetes After Transplantation - A Double-blind, Randomized, Placebo-controlled Trial[NCT00980356]	Phase 2	32 participants (Actual)	Interventional	2009-09-30	Completed
Intravenous Insulin Protocol in Diabetes and Renal Transplantation Study[NCT00609986]		104 participants (Actual)	Interventional	2007-07-31	Completed
The Effect of Sitagliptin Treatment on Glucose Metabolism and Endothelial Function in Renal Transplant Recipients - JANUVIA-08[NCT00740363]	Phase 4	25 participants (Actual)	Interventional	2008-09-30	Completed
Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia (TIP): Efficacy and Safety of a Novel Protocol in Renal Transplant Recipients Receiving a Tacrolimus-based Immunosuppression[NCT00830297]	Phase 2	50 participants (Actual)	Interventional	2009-01-31	Completed
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Post-transplantation Diabetes Mellitus[NCT03157414]	Phase 4	49 participants (Actual)	Interventional	2016-11-07	Completed
Randomized Controlled Trial Comparing the Metabolic Efficiency of Allogeneic Pancreatic Islet Transplantation to Intensive Insulin Therapy for the Treatment of Type 1 Diabetes[NCT01148680]	Phase 3	50 participants (Actual)	Interventional	2010-06-30	Completed
Glucose Control in Pre-Diabetic Renal Transplant Patients: Efficacy and Safety of Vildagliptin and Pioglitazone[NCT01346254]	Phase 2	51 participants (Actual)	Interventional	2009-12-31	Completed
Randomized Study of the Impact of Peri-operative Glucose Control on Short Term Renal Allograft Function After Transplantation[NCT01643382]		60 participants (Actual)	Interventional	2012-08-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Acute/Active Rejection

Grades IA through III and antibody immediate rejection, either A (immediate or hyperacute) or B (delayed or accelerated acute) were diagnosed and classified based on renal allograft biopsies according to the Banff 97 Working Classification of Renal Allograph Pathology. (NCT00609986)
Timeframe: 30 months

Intervention	participants (Number)
Intensive	9
Control	2

Delayed Graft Function

Need for dialysis in the first week post-transplant in a patient who required dialysis pre-transplantation or day-10 post-transplant creatinine concentration above 2.5 mg/dl. (NCT00609986)
Timeframe: 10 days

Intervention	participants (Number)
Intensive	8
Control	12

Severe Hyperglycemia

Blood glucose greater than 350 mg/dl. (NCT00609986)
Timeframe: 30 months

Intervention	participants (Number)
Intensive	5
Control	12

Severe Hypoglycemia

Blood glucose less than 40 mg/dl (NCT00609986)
Timeframe: 30 months

Intervention	participants (Number)
Intensive	7
Control	2

Incidence of Poor Graft Function After Kidney Transplant

Our primary endpoint will be poor initial graft function defined by the occurrence of DGF (defined by a decrease in serum creatinine of <10%/day for 3 consecutive days after transplant) or slow graft function (serum creatinine >3 mg/dL 5 days after transplant without dialysis) (NCT01643382)
Timeframe: 7 days after transplant

Intervention	Participants (Count of Participants)
Tight Glucose Control	13
Standard Glucose Control	22

Reviews

1 review available for pioglitazone and Complication, Postoperative

Article	Year
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020

Other Studies

2 other studies available for pioglitazone and Complication, Postoperative

Article	Year
PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice. International immunopharmacology, 2017, Volume: 43 Topics: Aging; Anilides; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cognitive Dysfunction;	2017
Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis. Fertility and sterility, 2011, Mar-15, Volume: 95, Issue:4 Topics: Animals; Disease Models, Animal; Endometriosis; Endometrium; Female; Humans; Mice; Mice, Nude; Piogl	2011